Dova Pharmaceuticals Inc. Human Resources Contracts & Agreements
15 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Compensation Agreements (2)
- Employment Agreements (7)
- Transition Agreements (2)
- Employment Agreement, by and between the Company and Jason Hoitt, dated as of December 17, 2018 (Filed With SEC on March 5, 2019)
- Employment Agreement, by and between the Company and David S. Zaccardelli, dated as of December 17, 2018 (Filed With SEC on March 5, 2019)
- Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on December 20, 2018)
- Amended and Restated 2017 Equity Incentive Plan, as amended (Filed With SEC on December 20, 2018)
- Amended and Restated Transition Services Agreement, dated as of April 1, 2018, by and between AkaRx, Inc. and Eisai Inc (Filed With SEC on November 8, 2018)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2018)
- Employment Agreement, by and between the Company and Mark W. Hahn, dated as of January 31, 2018 (Filed With SEC on January 31, 2018)
- DOVA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: JUNE 14, 2017 APPROVED BY THE STOCKHOLDERS: June 15, 2017 IPO DATE: ,... (Filed With SEC on June 19, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 2, 2017)
- DOVA PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on June 2, 2017)
- DOVA PHARMACEUTICALS, INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 28, 2017 APPROVED BY THE STOCKHOLDERS: APRIL 11, 2017 TERMINATION DATE: MARCH 27,... (Filed With SEC on June 2, 2017)
- TRANSITION SERVICES AGREEMENT by and between Eisai Inc. and AkaRx, Inc. Dated as of March 30, 2016 (Filed With SEC on June 2, 2017)
